Source: ERJ Open Res, 5 (3) 00066-2019; 10.1183/23120541.00066-2019
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Effrosyni D. Manali, Marie Legendre, Nadia Nathan, Caroline Kannengiesser, Aurore Coulomb-L'Hermine, Theofanis Tsiligiannis, Pericles Tomos, Matthias Griese, Raphael Borie, Annick Clement, Serge Amselem, Bruno Crestani, Spyros A. Papiris. Bi-allelic missense ABCA3 mutations in a patient with childhood ILD who reached adulthood. ERJ Open Res, 5 (3) 00066-2019; 10.1183/23120541.00066-2019

Member's Comments

No comment yet.

Related content which might interest you: Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis Source: Eur Respir J 2015; 46: 474-485 Year: 2015 Homozygous mutations of ARFGAP1 gene in severe sarcoidosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020 Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Pulmonary fibrosis in non-mutation carriers of families with short telomere syndrome gene mutations. Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021 Progressive lung disease caused by ABCA3 mutation Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020 First heterozygous NOP10 mutation in familial pulmonary fibrosis Source: Eur Respir J, 55 (6) 1902465; 10.1183/13993003.02465-2019 Year: 2020 Interstitial lung disease in a child heterozygous for the 1549C?GAA (121ins2) mutation of surfactant protein B Source: Eur Respir J 2011; 38: 985-987 Year: 2011 Sarcoidosis is associated with a truncating splice site mutation in the BTNL2 gene Source: Eur Respir J 2005; 26: Suppl. 49, 468s Year: 2005 Mutations in SFTPC, SFTPA2 and TERT explain 60% of familial pulmonary fibrosis and correlate to specific disease phenotypes Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 Lung disease caused by non-null ABCA3 mutations: long-term follow-up Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients Source: Eur Respir Rev 2014; 23: 390-392 Year: 2014 Intersitial lung disease in chlidren with mutation in the  SFTPC and SFPTB gene: A two case report Source: International Congress 2017 – Pulmonary infection and inflammation Year: 2017 Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C Source: Eur Respir J 2001; 17: 1195-1200 Year: 2001 Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension Source: Eur Respir J, 54 (2) 1801965; 10.1183/13993003.01965-2018 Year: 2019 A new SERPINA-1 missense mutation associated with alpha-1 antitrypsin deficiency and bronchiectasis. Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 Phenotype and outcome of PAH patients carrying a TBX4 mutation Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension Year: 2020 Somatic DICER1 mutations in adult-onset pulmonary blastoma Source: Eur Respir J 2016; 47:1879-1882 Year: 2016 First identified “severe” mutations and extended rearrangements in the CFTR gene in Russian cystic fibrosis patients Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020 High frequency of CFTR R75Q variant and mEPHX „slow" allele in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 343s Year: 2005 A new ABCA3 gene mutation in a now 2-yr-old boy Source: Annual Congress 2008 - The role of flexible bronchoscopy and bronchoalveolar lavage in lower airway disease Year: 2008